Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled t
Published at: archpsyc.ama-assn.org
-
Buprenorphine (Subutex) Shows Robust Benefits for Opioid Detoxification in Adolescents
April 3, 2006
While opioid dependence in adolescents may represent a narrower population as compared to the categories of mood disorders, ADHD, and anxiety disorders, this is a growing population for which there are no well-established treatments. That the Subutex arm was so robustly more effective across the outcome measures of treatment retention and transition into relapse prevention treatment is extremely encouraging for its use as a primary detoxification drug in adolescent opioid dependence.
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.